Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 4

The relationship of the immune response mediator genes' polymorphic variants with the methotrexate efficacy in juvenile idiopathic arthritis

Pages
1038–1047
Publication Date
2020-08-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: As a result of the study, the relationship of the alleles/genotypes of the IL1B rs16944, IL10 rs1800872, CTLA4 rs3087243, NFKB1 rs28362491 polymorphic loci and the TNFA rs1800629*A - LTA rs909253*G haplotype with the methotrexate efficacy in JIA was established taking into account the differences by sex .

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The aim of the study was to analyze the relationship of the immune response mediator genes' polymorphic loci TNFA rs1800629, LTA rs909253, IL1B rs16944, IL2-IL21 rs6822844, IL2RA rs2104286, IL6 rs1800795, IL10 rs1800872, MIF rs755622, CTLA4 rs3087243, NFKB1 rs28362491, PTPN22 rs2476601, PADI4 rs2240336 variants with the methotrexate efficacy in juvenile idiopathic arthritis JIA .
📊
Key Findings & Data:Materials and methods: The study included 274 JIA patients from the Republic of Bashkortostan, Russia.
💡
Conclusion & Impact:Conclusion: As a result of the study, the relationship of the alleles/genotypes of the IL1B rs16944, IL10 rs1800872, CTLA4 rs3087243, NFKB1 rs28362491 polymorphic loci and the TNFA rs1800629*A - LTA rs909253*G haplotype with the methotrexate efficacy in JIA was established taking into account the differences by sex .
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Juvenile idiopathic arthritis · polymorphic loci · methotrexate efficacy

Abstract

Background/aim: The aim of the study was to analyze the relationship of the immune response mediator genes' polymorphic loci TNFA rs1800629, LTA rs909253, IL1B rs16944, IL2-IL21 rs6822844, IL2RA rs2104286, IL6 rs1800795, IL10 rs1800872, MIF rs755622, CTLA4 rs3087243, NFKB1 rs28362491, PTPN22 rs2476601, PADI4 rs2240336 variants with the methotrexate efficacy in juvenile idiopathic arthritis JIA . Materials and methods: The study included 274 JIA patients from the Republic of Bashkortostan, Russia. Achieving the American College of Rheumatology Pediatric 30 ACR Pedi 30 response was regarded as the presence of the response to methotrexate otherwise, as the absence , while achieving clinical remission on medication Wallace et al., 2011 - as the sufficient response otherwise, as the insufficient . Genotyping was conducted by the real-time polymerase chain reaction. Results: Associations with an altered risk of the nonresponse to methotrexate in JIA were observed for the alleles/genotypes of the loci IL10 rs1800872 in girls and NFKB1 rs28362491 in girls ; with an altered risk of the insufficient response to methotrexate in JIA - for the alleles/genotypes of the loci IL1B rs16944 in boys , CTLA4 rs3087243 in boys , NFKB1 rs28362491 in girls and the haplotype TNFA rs1800629*A - LTA rs909253*G in girls . Conclusion: As a result of the study, the relationship of the alleles/genotypes of the IL1B rs16944, IL10 rs1800872, CTLA4 rs3087243, NFKB1 rs28362491 polymorphic loci and the TNFA rs1800629*A - LTA rs909253*G haplotype with the methotrexate efficacy in JIA was established taking into account the differences by sex .

🔖

Cite This Article

NAZAROVA, L., DANILKO, K., MALIEVSKY, V., KARIMOV, D., BAKIROV, A., VIKTOROVA, T. (2020). The relationship of the immune response mediator genes' polymorphic variants with the methotrexate efficacy in juvenile idiopathic arthritis. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 4, 1038–1047. https://ajindex.com/articles/113192

References (2)

  1. Petty RE, Southwood TR, Manners P, Baum J, Glass DN et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. The Journal of Rheumatology 2004; 31 (2): 390-392
  2. Kim KH, Kim DS. Juvenile idiopathic arthritis: DIAGNOSIS ANd differential diagnosis. Korean Journal of Pediatrics 2010; 53 (11): 931-935. doi: 10.3345/kjp.2010.53.11.931 3. Barut K, Adrovic A, Şahin S, Kasapçopur Ö. Juvenile idiopathic arthritis. Balkan Medical Journal 2017; 34 (2): 90-101. doi: 10.4274/balkanmedj.2017.0111 4. van Dijkhuizen EH, Wulffraat NM. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review. Pediatric Rheumatology 2014; 12: 51. doi: 10.1186/1546-0096-12-51 5. Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O’Neil KM et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis & Rheumatism 2012; 64 (6): 2012-2021. doi: 10.1002/art.34343 6. Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ et al. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care & Research 2011; 63 (4): 465-482. doi: 10.1002/acr.20460 7. Albarouni M, Becker I, Horneff G. Predictors of response to methotrexate in juvenile idiopathic arthritis. Pediatric Rheumatology 2014; 12: 35. doi: 10.1186/1546-0096-12-35 8. Roszkiewicz J, Smolewska E. In the pursuit of methotrexate treatment response biomarker in juvenile idiopathic arthritisare we getting closer to personalised medicine? Current Rheumatology Reports 2017; 19 (4): 19. doi: 10.1007/s11926- 017-0646-8 9. Pastore S, Stocco G, Favretto D, De Iudicibus S, Taddio A et al. Genetic determinants for methotrexate response in juvenile idiopathic arthritis. Frontiers in Pharmacology 2015; 6: 52. doi: 10.3389/fphar.2015.00052 10. Pawlik A, Baskiewicz-Masiuk M, Machalinski B, GawronskaSzklarz B. Association of cytokine gene polymorphisms and the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. International Immunopharmacology 2006; 6 (3): 351-357. doi: 10.1016/j. intimp.2005.08.019 11. Magyari L, Varszegi D, Kovesdi E, Sarlos P, Farago B et al. Interleukins and interleukin receptors in rheumatoid arthritis: Research, diag